Histone chaperone CAF-1 promotes HIV-1 latency by leading the formation of phase-separated suppressive nuclear bodies

Xiancai Ma,Tao Chen,Zhilin Peng,Ziwen Wang,Jun Liu,Tao Yang,Liyang Wu,Guangyan Liu,Mo Zhou,Muye Tong,Yuanjun Guan,Xu Zhang,Yingtong Lin,Xiaoping Tang,Linghua Li,Zhonghui Tang,Ting Pan,Hui Zhang
DOI: https://doi.org/10.15252/embj.2020106632
2021-01-01
The EMBO Journal
Abstract:HIV-1 latency is a major obstacle to achieving a functional cure for AIDS. Reactivation of HIV-1-infected cells followed by their elimination via immune surveillance is one proposed strategy for eradicating the viral reservoir. However, current latency-reversing agents (LRAs) show high toxicity and low efficiency, and new targets are needed to develop more promising LRAs. Here, we found that the histone chaperone CAF-1 (chromatin assembly factor 1) is enriched on the HIV-1 long terminal repeat (LTR) and forms nuclear bodies with liquid-liquid phase separation (LLPS) properties. CAF-1 recruits epigenetic modifiers and histone chaperones to the nuclear bodies to establish and maintain HIV-1 latency in different latency models and primary CD4(+) T cells. Three disordered regions of the CHAF1A subunit are important for phase-separated CAF-1 nuclear body formation and play a key role in maintaining HIV-1 latency. Disruption of phase-separated CAF-1 bodies could be a potential strategy to reactivate latent HIV-1.
What problem does this paper attempt to address?